Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
624.00    -3.00 (-0.48%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £543.66m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

AGM and Interim Management Statement

7 Feb 2012 07:00

RNS Number : 8868W
Victrex PLC
07 February 2012
 



For Stock Exchange release at 7.00 a.m. Tuesday 7 February 2012

 

Victrex plc

  

AGM and Interim Management Statement

 

At the Annual General Meeting of Victrex plc to be held today, Chairman Anita Frew will make the following statement which comprises Victrex's Interim Management Statement covering the period from 1 October 2011 to date:

  

"We are pleased to announce that, following the de-stocking reported in our Victrex Polymer Solutions business ('VPS') in Q1 of our financial year, Group sales volume for January came back strongly at 288 tonnes (2011: 265 tonnes). This brings the four month total Group sales volume to 870 tonnes.

 

We remain mindful of the continuing economic uncertainty and the impact it may have on VPS sales volume for the full year. However, the current order book for February and new business development activity are encouraging.

 

Our Invibio Biomaterial Solutions business has made a solid start to the financial period and we continue to expect growth for the year.

 

There have been no significant changes in the financial position of the Company since 30 September 2011 and the Group remains in an excellent financial position with a healthy balance sheet and strong cash generation.

 

Our capacity expansion plans are on track and we continue to invest in new application development and technical leadership to ensure we capitalise on the growth potential for our business."

 

 

 

 

Victrex will host a conference call at 8.00 a.m. today for analysts. If you would like more details, please contact Naomi Lane at MHP on 0203 128 8204 / Naomi.Lane@mhpc.com.

 

The Group will also hold an investor day for institutional investors and analysts in London tomorrow, Wednesday 8 February, focusing on its VPS division. No new trading or price sensitive information will be disclosed. A copy of the presentation will be made available on Victrex's website following the event.

 

Victrex will provide a trading update for the six months to 31 March 2012 on Thursday 5 April 2012.

 

 

Enquiries

 

Victrex plc

Anita Frew, Chairman 0203 128 8100 (7 February 2012)

David Hummel, Chief Executive 01253 897700 (thereafter)

Steve Barrow, Finance Director

 

MHP Communications

Nick Denton / Barnaby Fry / Ian Payne 0203 128 8100

 

Victrex plc is an innovative world leader in high performance materials through the manufacture of VICTREX® PEEK polymer, a high performance, easy to process thermoplastic.

 

With over 30 years of experience, Victrex is a provider of innovative, high performance thermoplastic polymers. We work with customers and end users globally to deliver technology driven solutions to the challenges and opportunities they face. Our Victrex Polymer Solutions business unit ('VPS') focuses on our transport, industrial and electronics markets and our Invibio® Biomaterial Solutions business unit ('Invibio') focuses on providing specialist solutions for medical device manufacturers.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMDMGGZKVGGZZM
Date   Source Headline
11th Oct 20194:18 pmRNSHolding(s) in Company
8th Oct 20193:09 pmRNSHolding(s) in Company
7th Oct 20194:06 pmRNSHolding(s) in Company
3rd Oct 20194:18 pmRNSHolding(s) in Company
30th Sep 201911:53 amRNSTotal Voting Rights
18th Sep 20199:19 amRNSDirector/PDMR Shareholding
30th Aug 20199:00 amRNSTotal Voting Rights
19th Aug 201911:44 amRNSDirector/PDMR Shareholding
14th Aug 201910:39 amRNSHolding(s) in Company
31st Jul 20199:01 amRNSTotal Voting Rights
25th Jul 20197:00 amRNSInterim Management Statement
17th Jul 201910:38 amRNSDirector/PDMR Shareholding
28th Jun 20199:00 amRNSTotal Voting Rights
24th Jun 20197:00 amRNSDirectorate Change
18th Jun 201910:42 amRNSDirector/PDMR Shareholding
3rd Jun 20191:55 pmRNSBlock listing Interim Review
31st May 20193:12 pmRNSDirector/PDMR Shareholding
31st May 20199:00 amRNSTotal Voting Rights
20th May 201910:09 amRNSDirector/PDMR Shareholding
17th May 201910:50 amRNSDirector/PDMR Shareholding
15th May 20198:49 amRNSDirector/PDMR Shareholding
13th May 20197:00 amRNSHalf-year Report
30th Apr 201910:00 amRNSTotal Voting Rights
17th Apr 201912:03 pmRNSDirector/PDMR Shareholding
29th Mar 201912:07 pmRNSTotal Voting Rights
19th Mar 201910:55 amRNSDirector/PDMR Shareholding
28th Feb 20199:33 amRNSTotal Voting Rights
19th Feb 201910:42 amRNSDirector/PDMR Shareholding
18th Feb 20194:23 pmRNSDirector/PDMR Shareholding
11th Feb 20194:34 pmRNSHolding(s) in Company
8th Feb 20199:44 amRNSHolding(s) in Company
6th Feb 20192:28 pmRNSResult of AGM
6th Feb 20191:55 pmRNSDirector/PDMR Shareholding
6th Feb 20197:00 amRNSAGM and Q1 Interim Management Statement
4th Feb 201912:18 pmRNSDirector/PDMR Shareholding
31st Jan 20199:29 amRNSTotal Voting Rights
28th Jan 20194:28 pmRNSHolding(s) in Company
17th Jan 201911:21 amRNSDirector/PDMR Shareholding
11th Jan 20193:44 pmRNSHolding(s) in Company
3rd Jan 20191:00 pmRNSAnnual Financial Report
31st Dec 20189:00 amRNSTotal Voting Rights
18th Dec 20183:19 pmRNSDirector/PDMR Shareholding
18th Dec 201810:30 amRNSDirector/PDMR Shareholding
17th Dec 201811:40 amRNSDirector/PDMR Shareholding
11th Dec 20189:50 amRNSDirector/PDMR Shareholding
11th Dec 20189:48 amRNSDirector/PDMR Shareholding
5th Dec 20181:47 pmRNSDirector/PDMR Shareholding
5th Dec 201812:35 pmRNSDirector/PDMR Shareholding
4th Dec 20187:00 amRNSPreliminary Results 2018
3rd Dec 20189:25 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.